STRS Ohio’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

STRS Ohio’s Portfolio SYRS Stock Details SYRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-150	Closed	-$14K	–	1923
2017 Q4	$14K	Hold	150	–	–	﹤0.01%	1837
2017 Q3	$22K	Hold	150	–	–	﹤0.01%	1864
2017 Q2	$24K	Hold	150	–	–	﹤0.01%	1871
2017 Q1	$23K	Hold	150	–	–	﹤0.01%	1825
2016 Q4	$18K	Hold	150	–	–	﹤0.01%	1864
2016 Q3	$20K	Buy	+150	New	+$19K	﹤0.01%	1844

Other funds holding SYRS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

STRS Ohio's SYRS Position: Q1 2018 in Review

STRS Ohio sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q1 2018, closing a stake of 150 shares — an estimated $14K sold.

STRS Ohio first reported a position in SYRS in Q3 2016 and held it in 6 quarters. The position peaked at $24K in Q2 2017. 57 funds tracked by Wall St. Rank hold SYRS as of Q1 2018.

STRS Ohio reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
STRS Ohio sold 150 Syros Pharmaceuticals, Inc. Common Stock shares in Q1 2018, an estimated $14K.
STRS Ohio first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q3 2016 and held it in 6 quarters.
STRS Ohio's Syros Pharmaceuticals, Inc. Common Stock position peaked at $24K in Q2 2017.
57 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q1 2018.

Based on STRS Ohio's 13F filing for Q1 2018, filed 20 Apr 2018.